US FDA Chief Faces Scrutiny Over Drug Approvals
The head of the US Food and Drug Administration (FDA) is facing scrutiny, particularly regarding his handling of drug approvals. This comes amid broader concerns about the agency's processes.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
NPR
“President Trump referenced Dr. Martin McCary and PR has learned that McC ary is expected to resign as commissioner of the Food and Drug”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade